• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?

作者信息

Sahmoud T, Mary J Y, Sahmoud T

机构信息

INSERM U 444, Université Paris 7, France.

出版信息

Gut. 1997 Feb;40(2):284-5. doi: 10.1136/gut.40.2.284.

DOI:10.1136/gut.40.2.284
PMID:9071946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1027063/
Abstract
摘要

相似文献

1
Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?美沙拉嗪作为克罗恩病的维持治疗药物：它是人们期待已久的解决方案吗？
Gut. 1997 Feb;40(2):284-5. doi: 10.1136/gut.40.2.284.
2
Drug choice in preventing postoperative Crohn's disease.预防术后克罗恩病的药物选择
Gastroenterology. 1996 Feb;110(2):652-3. doi: 10.1053/gast.1996.v110.agast960652.
3
The role of mesalazine in Crohn's disease.美沙拉嗪在克罗恩病中的作用。
Scand J Gastroenterol Suppl. 1990;172:56-9. doi: 10.3109/00365529009091912.
4
The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.美沙拉嗪与尼古丁在炎症性肠病治疗中的作用
Ann Pharmacother. 1997 Jul-Aug;31(7-8):907-13. doi: 10.1177/106002809703100719.
5
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.美沙拉嗪维持克罗恩病缓解的随机、安慰剂对照、双盲试验。加拿大美沙拉嗪治疗克罗恩病缓解研究组。
Gastroenterology. 1997 Apr;112(4):1069-77. doi: 10.1016/s0016-5085(97)70117-3.
6
Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.柳氮磺胺吡啶和美沙拉嗪用于克罗恩病维持治疗的荟萃分析
Am J Gastroenterol. 1994 Dec;89(12):2116-24.
7
Mesalazine as maintenance treatment in Crohn's disease.美沙拉嗪作为克罗恩病的维持治疗药物。
Gastroenterology. 1994 Feb;106(2):553-4. doi: 10.1016/0016-5085(94)90624-6.
8
A controlled double blind multicenter study of the effectiveness of 5-aminosalicylic acid in patients with Crohn's disease in remission.
J Clin Gastroenterol. 1995 Apr;20(3):203-6. doi: 10.1097/00004836-199504000-00008.
9
Drug insight: aminosalicylates for the treatment of IBD.药物洞察：用于治疗炎症性肠病的氨基水杨酸类药物。
Nat Clin Pract Gastroenterol Hepatol. 2007 Mar;4(3):160-70. doi: 10.1038/ncpgasthep0696.
10
[Pentasa (mesalazine) and pregnancy].[颇得斯安（美沙拉嗪）与妊娠]
Therapie. 1994 Sep-Oct;49(5):443-5.

引用本文的文献

1
Cost-Effectiveness of Budesonide Controlled Ileal Release (CIR) Capsules as Maintenance Therapy versus No Maintenance Therapy for Ileocaecal Crohn's Disease in Sweden.布地奈德控释环（CIR）胶囊维持治疗与不维持治疗对瑞典回肠型克罗恩病的成本效益比较。
Clin Drug Investig. 1998;15(2):123-36. doi: 10.2165/00044011-199815020-00006.

本文引用的文献

1
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.美沙拉嗪在克罗恩病类固醇诱导缓解中的应用：对类固醇撤药及缓解维持的影响，消化系炎症性疾病治疗研究组
Gastroenterology. 1996 Mar;110(3):688-93. doi: 10.1053/gast.1996.v110.pm8608877.
2
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.接受硫唑嘌呤或6-巯基嘌呤治疗的克罗恩病患者的长期随访
Lancet. 1996 Jan 27;347(8996):215-9. doi: 10.1016/s0140-6736(96)90402-x.
3
Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.识别静止期克罗恩病复发高风险患者。GETAID研究组。消化系炎症性疾病治疗研究组。
Gut. 1995 Dec;37(6):811-8. doi: 10.1136/gut.37.6.811.
4
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).口服美沙拉嗪（颇得斯安）用于克罗恩病维持治疗：一项多中心安慰剂对照研究。消化系炎症治疗研究组（GETAID）
Gastroenterology. 1993 Feb;104(2):435-9. doi: 10.1016/0016-5085(93)90411-5.
5
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).口服美沙拉嗪（5-氨基水杨酸；艾迪莎）预防克罗恩病术后复发。意大利结直肠研究组（GISC）。
Aliment Pharmacol Ther. 1994 Feb;8(1):35-43. doi: 10.1111/j.1365-2036.1994.tb00158.x.
6
Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis.5-氨基水杨酸维持克罗恩病患者缓解的有效性：一项荟萃分析。
Am J Gastroenterol. 1994 May;89(5):692-8.
7
Meta-analysis of the literature or of individual patient data: is there a difference?文献的Meta分析或个体患者数据的Meta分析：有区别吗？
Lancet. 1993 Feb 13;341(8842):418-22. doi: 10.1016/0140-6736(93)93004-k.
8
European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.欧洲克罗恩病合作研究（ECCDS）：药物治疗结果
Gastroenterology. 1984 Feb;86(2):249-66.
9
Controlled trial of azathioprine in Crohn's disease.
Lancet. 1971 Oct 30;2(7731):944-7. doi: 10.1016/s0140-6736(71)90268-6.
10
A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease.一种用于预测克罗恩病无症状患者复发的实验室指标。
Gastroenterology. 1986 Dec;91(6):1490-4. doi: 10.1016/0016-5085(86)90206-4.